G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).

Biotechnology

G1 Therapeutics

Amanda Jacobson

Shannon Lusk

Whitney Page

John Umstead V

Jeremy Paul Ware

Raj Malik

Daniel Barnes

Darlene Burns

Daren Hill

Kyle D.

Will Roberts

Greg Maxfield

Annie McCoy

Olu O. Oyeneye

Sandi James

Monica Thomas

Mike Townsend

The Analytics and Development team at G1 Therapeutics leverages data analytics and strategic insights to support the commercialization of innovative cancer therapies. This team collaborates across departments to optimize operational efficiency, enhance decision-making through statistical programming, and ensure robust financial planning and analysis to drive the company's growth and success in the biopharmaceutical landscape.

Analytics and Development

Oncology Sales and Marketing

Marketing and Communications

Leadership Team

Analytics and Development

About

Team members

Other teams at G1 Therapeutics

Oncology Sales and Marketing

Marketing and Communications

Leadership Team